As of this month, the Japan Agency for Medical Research and Development will have been established to improve medical care, and help develop drugs and medical equipment in the country. It will distribute the ¥140 billion ($1.16 billion) research budget of several ministries across nine fields that the Japanese government considers important. The areas are […]
In March, DeCode Genetics published four papers in Nature Genetics on its study sequencing the genomes of 2,636 Icelanders. The research detected rare mutations protecting individuals against disease, and the company reported finding more than 20 million genetic variants. Some of these variants were associated with increased risks for conditions, including a gene associated with […]
The US FDA is experiencing insufficient funding to carry out the steps required by the Food Safety Modernization Act (FSMA) of 2010 (see IBO 12/31/10). According to the Congressional Budget Office, the FDA would have needed $580 million to do this from 2011 to 2015. However, less than half of the amount has been appropriated. […]
Washington, DC 4/6/15; Morgantown, VA 4/7/15; Bundorra, Canada 4/7/15—Protea Biosciences, a supplier of bioanalytical solutions, has agreed to acquire vivoPharm for $11.1 million in cash and stock. vivoPharm provides pharmacology, toxicology and bioanalytical research services, including oncology models. “vivoPharm has developed a large standard-of-care reference database. We believe that this critical asset, together with Protea’s […]
Fourth quarter 2014 IBO Lab Equipment/Consumables Sales Index revenues grew 4.6%, 6.3% excluding currency, to $4,679 million. Growth was driven by strong results for Thermo Fisher Scientific Laboratory Products and Services (LPS). Index adjusted operating profit improved only 0.3% to $811 million. Operating margin declined 70 basis points to 15.7% of sales due to divestments, […]
Washington, DC 4/6/15—OpGen has disclosed in an SEC filing for its IPO (see IBO 3/15/15) that it plans to offer 3,750,000 shares of common stock at a price of $8–$10 per share. Assuming a price of $9 per share, the company expects to raise $30.5 million, or $35 million if underwriters exercise their option.
Aliso Viejo, CA 4/1/15—Ambry Genetics, a clinical genetics testing lab, has acquired Progeny Software, a provider of genotype management and analysis software, and LIMS systems, for an undisclosed amount. “We were starting to build tools like this internally, but then I met Michael Brammer and within 24 hours we had an agreement. I realized how […]
Port Washington, NY 3/31/15—Pall, a provider of filtration, separation and purification products for industrial and life science markets, has announced the acquisition of Tarpon Biosystems’ BioSMB (simulated moving bed) technology for an undisclosed amount. BioSMB technology is designed for single-use, multicolumn chromatography from process development through large-scale production. “It extends our process intensification and continuous […]
London, UK 4/15/15—LGC, a life science–measurement and –testing company, has agreed to acquire Biosearch Technologies, a designer, developer and manufacturer of custom oligonucleotides and associated reagents for medical diagnostic, research and applied markets. The financial amount was not disclosed. Biosearch has 170 employees in the US and Europe. “Both LGC and Biosearch have a complementary […]
Cannabis testing in the US has made progress on multiple fronts but still has a long way to go, resulting in new opportunities for lab product and instrumentation companies. Testing demand is growing as more states legalize recreational use, and institute testing and lab requirements. But the fragmented market and unique business environment creates challenges […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
